KENNETH NWOGU: Open Payments
NPI 1891340808 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,535 in 72 payments from 9 companies in 2025. Trend: 2023 $741 · 2024 $1,674 · 2025 $1,535
Food & beverage: $1,535
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $358 |
| ABBVIE INC. | 22 | $249 |
| Indivior Inc. | 17 | $238 |
| Otsuka America Pharmaceutical, Inc. | 7 | $195 |
| Braeburn Inc. | 5 | $182 |
| Supernus Pharmaceuticals, Inc. | 3 | $157 |
| Vanda Pharmaceuticals Inc. | 3 | $64 |
| Axsome Therapeutics, Inc. | 3 | $62 |
| Exact Sciences Corporation | 1 | $29 |
Products named: CAPLYTA, VRAYLAR, SUBLOCADE, BRIXADI, ABILIFY MAINTENA, Qelbree, FANAPT, Auvelity.
Industry payments across OH — which companies pay providers there.
